Annual Total Debt
$445.06 M
-$7.06 M-1.56%
December 31, 2023
Summary
- As of February 8, 2025, FOLD annual total debt is $445.06 million, with the most recent change of -$7.06 million (-1.56%) on December 31, 2023.
- During the last 3 years, FOLD annual total debt has risen by +$3.33 million (+0.75%).
- FOLD annual total debt is now -1.56% below its all-time high of $452.12 million, reached on December 31, 2022.
Performance
FOLD Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$444.66 M
+$600.00 K+0.14%
September 30, 2024
Summary
- As of February 8, 2025, FOLD quarterly total debt is $444.66 million, with the most recent change of +$600.00 thousand (+0.14%) on September 30, 2024.
- Over the past year, FOLD quarterly total debt has dropped by -$9.63 million (-2.12%).
- FOLD quarterly total debt is now -2.12% below its all-time high of $454.29 million, reached on September 30, 2023.
Performance
FOLD Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
FOLD Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -1.6% | -2.1% |
3 y3 years | +0.8% | -2.1% |
5 y5 years | +38.3% | -2.1% |
FOLD Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -1.6% | +1.1% | -2.1% | +1.0% |
5 y | 5-year | -1.6% | +111.7% | -2.1% | +119.9% |
alltime | all time | -1.6% | -100.0% | -2.1% | -100.0% |
Amicus Therapeutics Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $444.66 M(+0.1%) |
Jun 2024 | - | $444.06 M(-0.1%) |
Mar 2024 | - | $444.49 M(-0.1%) |
Dec 2023 | $445.06 M(-1.6%) | $445.06 M(-2.0%) |
Sep 2023 | - | $454.29 M(+0.5%) |
Jun 2023 | - | $452.17 M(+0.0%) |
Mar 2023 | - | $452.01 M(-0.0%) |
Dec 2022 | $452.12 M(+2.7%) | $452.12 M(+0.3%) |
Sep 2022 | - | $450.87 M(-0.0%) |
Jun 2022 | - | $451.04 M(+0.7%) |
Mar 2022 | - | $447.71 M(+1.7%) |
Dec 2021 | $440.13 M(-0.4%) | $440.13 M(+0.2%) |
Sep 2021 | - | $439.39 M(-0.5%) |
Jun 2021 | - | $441.74 M(+0.2%) |
Mar 2021 | - | $440.98 M(-0.2%) |
Dec 2020 | $441.73 M(+110.1%) | $441.73 M(+0.3%) |
Sep 2020 | - | $440.58 M(+117.9%) |
Jun 2020 | - | $202.22 M(-3.6%) |
Mar 2020 | - | $209.76 M(-0.2%) |
Dec 2019 | $210.22 M(-34.7%) | $210.22 M(+2.4%) |
Sep 2019 | - | $205.30 M(+9.2%) |
Jun 2019 | - | $188.00 M(-9.4%) |
Mar 2019 | - | $207.44 M(-35.5%) |
Dec 2018 | $321.74 M(+96.0%) | $321.74 M(+0.9%) |
Sep 2018 | - | $318.81 M(+88.2%) |
Jun 2018 | - | $169.44 M(+1.6%) |
Mar 2018 | - | $166.77 M(+1.6%) |
Dec 2017 | $164.17 M(+6.1%) | $164.17 M(+1.6%) |
Sep 2017 | - | $161.63 M(+1.5%) |
Jun 2017 | - | $159.17 M(+1.5%) |
Mar 2017 | - | $156.86 M(+1.4%) |
Dec 2016 | $154.75 M(+272.0%) | $154.75 M(+134.4%) |
Sep 2016 | - | $66.02 M(+1.1%) |
Jun 2016 | - | $65.29 M(+69.6%) |
Mar 2016 | - | $38.51 M(-7.4%) |
Dec 2015 | $41.60 M(+189.9%) | $41.60 M(-16.8%) |
Sep 2015 | - | $50.00 M(>+9900.0%) |
Jun 2015 | - | $0.00(-100.0%) |
Mar 2015 | - | $14.40 M(+0.3%) |
Dec 2014 | $14.35 M | $14.35 M(+0.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2014 | - | $14.30 M(-0.4%) |
Jun 2014 | - | $14.36 M(-0.4%) |
Mar 2014 | - | $14.41 M(-0.4%) |
Dec 2013 | $14.47 M(+1976.5%) | $14.47 M(+3536.4%) |
Sep 2013 | - | $398.00 K(-20.1%) |
Jun 2013 | - | $498.00 K(-16.6%) |
Mar 2013 | - | $597.00 K(-14.3%) |
Dec 2012 | $697.00 K(-33.2%) | $697.00 K(-22.6%) |
Sep 2012 | - | $900.00 K(-31.5%) |
Jun 2012 | - | $1.31 M(-23.9%) |
Mar 2012 | - | $1.73 M(+65.3%) |
Dec 2011 | $1.04 M(-55.3%) | $1.04 M(-23.1%) |
Sep 2011 | - | $1.36 M(-18.8%) |
Jun 2011 | - | $1.67 M(-15.8%) |
Mar 2011 | - | $1.98 M(-15.1%) |
Dec 2010 | $2.34 M(-40.1%) | $2.34 M(-13.3%) |
Sep 2010 | - | $2.70 M(-12.0%) |
Jun 2010 | - | $3.06 M(-12.1%) |
Mar 2010 | - | $3.49 M(-10.6%) |
Dec 2009 | $3.90 M(+226.8%) | $3.90 M(-8.0%) |
Sep 2009 | - | $4.24 M(+54.0%) |
Jun 2009 | - | $2.75 M(+200.0%) |
Mar 2009 | - | $918.00 K(-23.1%) |
Dec 2008 | $1.19 M(-56.1%) | $1.19 M(-24.1%) |
Sep 2008 | - | $1.57 M(-19.5%) |
Jun 2008 | - | $1.95 M(-16.5%) |
Mar 2008 | - | $2.34 M(-14.1%) |
Dec 2007 | $2.72 M(-23.6%) | $2.72 M(-12.1%) |
Sep 2007 | - | $3.09 M(-10.5%) |
Jun 2007 | - | $3.46 M(+6.4%) |
Mar 2007 | - | $3.25 M(-8.8%) |
Dec 2006 | $3.56 M(+251.5%) | $3.56 M(>+9900.0%) |
Sep 2006 | - | $0.00(0.0%) |
Jun 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(-100.0%) |
Dec 2005 | $1.01 M(>+9900.0%) | $1.01 M(>+9900.0%) |
Sep 2005 | - | $0.00(0.0%) |
Jun 2005 | - | $0.00(0.0%) |
Mar 2005 | - | $0.00 |
Dec 2004 | $0.00(0.0%) | - |
Dec 2003 | $0.00 | - |
FAQ
- What is Amicus Therapeutics annual total debt?
- What is the all time high annual total debt for Amicus Therapeutics?
- What is Amicus Therapeutics annual total debt year-on-year change?
- What is Amicus Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly total debt year-on-year change?
What is Amicus Therapeutics annual total debt?
The current annual total debt of FOLD is $445.06 M
What is the all time high annual total debt for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total debt is $452.12 M
What is Amicus Therapeutics annual total debt year-on-year change?
Over the past year, FOLD annual total debt has changed by -$7.06 M (-1.56%)
What is Amicus Therapeutics quarterly total debt?
The current quarterly total debt of FOLD is $444.66 M
What is the all time high quarterly total debt for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total debt is $454.29 M
What is Amicus Therapeutics quarterly total debt year-on-year change?
Over the past year, FOLD quarterly total debt has changed by -$9.63 M (-2.12%)